Citadel Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-84,499
| Closed | -$262K | – | 15357 |
|
|
2021
Q4 | $262K | Buy |
84,499
+68,424
| +426% | +$230K | ﹤0.01% | 11237 |
|
|
2021
Q3 | $58K | Buy |
+16,075
| New | +$60.6K | ﹤0.01% | 13288 |
|
|
2021
Q1 | – | Sell |
-72,865
| Closed | -$301K | – | 14115 |
|
|
2020
Q4 | $306K | Sell |
72,865
-127,695
| -64% | -$492K | ﹤0.01% | 9045 |
|
|
2020
Q3 | $748K | Sell |
200,560
-57,868
| -22% | -$246K | ﹤0.01% | 6568 |
|
|
2020
Q2 | $1.13M | Buy |
258,428
+33,364
| +15% | +$150K | ﹤0.01% | 5614 |
|
|
2020
Q1 | $853K | Sell |
225,064
-700,445
| -76% | -$3.44M | ﹤0.01% | 5611 |
|
|
2019
Q4 | $5.85M | Buy |
925,509
+753,711
| +439% | +$4.43M | ﹤0.01% | 2896 |
|
|
2019
Q3 | $723K | Sell |
171,798
-121,314
| -41% | -$518K | ﹤0.01% | 6149 |
|
|
2019
Q2 | $1.36M | Buy |
293,112
+123,852
| +73% | +$577K | ﹤0.01% | 5180 |
|
|
2019
Q1 | $897K | Buy |
169,260
+148,437
| +713% | +$678K | ﹤0.01% | 5780 |
|
|
2018
Q4 | $77K | Sell |
20,823
-67,216
| -76% | -$236K | ﹤0.01% | 8363 |
|
|
2018
Q3 | $246K | Buy |
88,039
+10,455
| +13% | +$29.3K | ﹤0.01% | 7903 |
|
|
2018
Q2 | $229K | Buy |
77,584
+61,820
| +392% | +$147K | ﹤0.01% | 7664 |
|
|
2018
Q1 | $35K | Sell |
15,764
-70,808
| -82% | -$166K | ﹤0.01% | 8017 |
|
|
2017
Q4 | $255K | Buy |
86,572
+11,408
| +15% | +$31.5K | ﹤0.01% | 6717 |
|
|
2017
Q3 | $222K | Buy |
75,164
+61,149
| +436% | +$186K | ﹤0.01% | 6540 |
|
|
2017
Q2 | $39K | Buy |
+14,015
| New | +$29.6K | ﹤0.01% | 7164 |
|
|
2017
Q1 | – | Sell |
-68,585
| Closed | -$132K | – | 8561 |
|
|
2016
Q4 | $120K | Buy |
68,585
+50,162
| +272% | +$102K | ﹤0.01% | 6606 |
|
|
2016
Q3 | $50K | Sell |
18,423
-17,710
| -49% | -$45K | ﹤0.01% | 6854 |
|
|
2016
Q2 | $85K | Sell |
36,133
-59,228
| -62% | -$163K | ﹤0.01% | 6262 |
|
|
2016
Q1 | $308K | Sell |
95,361
-674,835
| -88% | -$2.49M | ﹤0.01% | 5063 |
|
|
2015
Q4 | $3.69M | Buy |
770,196
+691,060
| +873% | +$3.92M | ﹤0.01% | 2098 |
|
|
2015
Q3 | $440K | Buy |
79,136
+62,577
| +378% | +$462K | ﹤0.01% | 4984 |
|
|
2015
Q2 | $132K | Sell |
16,559
-383,447
| -96% | -$3.29M | ﹤0.01% | 6799 |
|
|
2015
Q1 | $4.2M | Sell |
400,006
-75,187
| -16% | -$1.03M | ﹤0.01% | 2215 |
|
|
2014
Q4 | $5.71M | Buy |
475,193
+397,646
| +513% | +$6.04M | 0.01% | 1859 |
|
|
2014
Q3 | $1.32M | Sell |
77,547
-15,473
| -17% | -$225K | ﹤0.01% | 3349 |
|
|
2014
Q2 | $1.12M | Buy |
93,020
+82,420
| +778% | +$781K | ﹤0.01% | 3352 |
|
|
2014
Q1 | $89K | Buy |
+10,600
| New | +$85.5K | ﹤0.01% | 6313 |
|
Other funds holding BDSI
Citadel Advisors's BDSI Position: Q1 2022 in Review
Citadel Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 84,499 shares — an estimated $262K sold.
Citadel Advisors first reported a position in BDSI in Q1 2014 and held it in 29 quarters. The position peaked at $5.85M in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.
- Citadel Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
- Citadel Advisors sold 84,499 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $262K.
- Citadel Advisors first reported a position in BioDelivery Sciences International, Inc. in Q1 2014 and held it in 29 quarters.
- Citadel Advisors's BioDelivery Sciences International, Inc. position peaked at $5.85M in Q4 2019.
- 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.